ArticleClinical and experimental nephrology2018

Rationale, design, and characteristics of a trial to evaluate the new phosphate iron-based binder sucroferric oxyhydroxide in dialysis patients with the goal of advancing the practice of E.B.M. (EPISODE).

Yoshitaka Isaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.